Regulus Therapeutics
RGLS
₹118.28
Share price
0.74%
Change (1 day)
-48.88%
Change (1 year)
Categories
Regulus Therapeutics (RGLS) - Cash on Hand
Cash on Hand as of September 2024 : ₹7.53 Billion
According to Regulus Therapeutics's latest financial reports the company has ₹7.53 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Regulus Therapeutics - Cash on Hand chart (from 2011 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | ₹1.97 B | -38.94% |
| 2022-12-31 | ₹3.24 B | -27.9% |
| 2021-12-31 | ₹4.49 B | 97.68% |
| 2020-12-31 | ₹2.27 B | -6.56% |
| 2019-12-31 | ₹2.43 B | 149.72% |
| 2018-12-31 | ₹0.97 B | -74.6% |
| 2017-12-31 | ₹3.83 B | -25.84% |
| 2016-12-31 | ₹5.17 B | -31.77% |
| 2015-12-31 | ₹7.58 B | -25.13% |
| 2014-12-31 | ₹10.12 B | 43.74% |
| 2013-12-31 | ₹7.04 B | 31.13% |
| 2012-12-31 | ₹5.37 B | 166.19% |
| 2011-12-31 | ₹2.01 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | ₹402.38 B | 5,238.20% | 🇬🇧 UK |
 | ₹712.18 B | 9,348.01% | 🇫🇷 France |
 | ₹205.04 B | 2,620.22% | 🇺🇸 USA |
 | ₹488.14 B | 6,375.85% | 🇬🇧 UK |
 | ₹232.63 B | 2,986.17% | 🇺🇸 USA |
 | ₹3.38 B | -55.10% | 🇺🇸 USA |
 | ₹937.52 B | 12,337.43% | 🇺🇸 USA |
 | N/A | N/A | 🇺🇸 USA |